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Retinal Microvascular Abnormalities and Cognitive
Impairment in Middle-Aged Persons
The Atherosclerosis Risk in Communities Study
Tien Yin Wong, MD, MPH; Ronald Klein, MD, MPH; A. Richey Sharrett, MD, DrPH;
F. Javier Nieto, MD, PhD; Lori L. Boland, MPH; David J. Couper, PhD; Thomas H. Mosley, MD;
Barbara E.K. Klein, MD, MPH; Larry D. Hubbard, MAT; Moyses Szklo, MD, DrPH
Background and Purpose—Cerebral microvascular disease has been hypothesized to contribute to cognitive impairment,
but few clinical data are available. Here, we examine the relation of retinal microvascular abnormalities with cognitive
function in middle-aged persons free of stroke.
Methods—The Atherosclerosis Risk in Communities Study is a population-based study with examinations every 3 years
from 1987 through 1998. At visit 3, when participants were 51 to 70 years of age, retinal photographs were obtained
and evaluated for retinal microvascular abnormalities according to standardized protocols. Cognitive function was
assessed with standardized tests (Delayed Word Recall Test, Digit Symbol Subtest, and Word Fluency Test) at visits 2
and 4 and averaged for analysis. Persons with stroke or taking central nervous system–relevant medications were
excluded, leaving 8734 with data for this study.
Results—After education, diabetes mellitus, blood pressure, carotid intima-media thickness, and other risk factors were
controlled for, retinopathy was associated with lower cognitive test scores. The adjusted odds ratios for persons with
Delayed Word Recall scores 2 SD or lower than the mean were 2.60 [95% confidence interval (CI), 1.30 to 2.91] for
any retinopathy, 3.00 (95% CI, 1.81 to 4.98) for microaneurysms, 3.39 (95% CI, 1.99 to 5.78) for retinal hemorrhage,
and 3.07 (95% CI, 1.53 to 6.17) for soft exudates. Results were similar for the other 2 cognitive tests and in people with
and without diabetes and hypertension.
Conclusions—Retinopathy is independently associated with poorer cognitive function in middle-aged persons without
stroke, suggesting that cerebral microvascular disease may contribute to the development of cognitive impairment.
(Stroke. 2002;33:1487-1492.)
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Although cognitive impairment is an important cause ofmorbidity in elderly persons, its pathogenesis remains
poorly understood.1 Cerebral microvascular disease has been
hypothesized to contribute to the development of vascular
cognitive impairment2,3 and to modify the risk and course of
Alzheimer’s disease.4–7 In support of such a hypothesis,
associations of cognitive impairment with a number of
microvascular risk factors such as hypertension,8–10 diabetes
mellitus,10,11 cigarette smoking,12 and inflammation13 have
been described. Additionally, pathological studies have dem-
onstrated cerebral microvascular alterations (eg, tortuosity
and narrowing of arterioles) among the characteristic degen-
erative changes associated with dementia.14–18
Nevertheless, few clinical data are available to support an
association between microvascular disease and cognitive
impairment, particularly in the general population. In part, the
reason is that the cerebral microcirculation is difficult to
evaluate outside highly specialized settings.19,20 The retinal
arterioles provide a unique opportunity to study the conse-
quences of cerebral microvascular disease because they can
be viewed noninvasively and because their anatomy, physi-
ology, and embryology are similar to those of cerebral
arterioles.21 Retinal microvascular abnormalities related to
aging, hypertension, and other processes have therefore been
suggested to reflect similar pathology in the cerebral
microcirculation.22
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In the Atherosclerosis Risk in Communities (ARIC) study,
retinal photographs were obtained of participants at the third
visit and graded for retinal microvascular characteristics
according to standardized methods.23 We have previously
reported that retinal microvascular abnormalities were related
to concurrently measured blood pressure and were indepen-
dently related to past blood pressure24 and various markers of
inflammation and endothelial dysfunction.25 We have also
shown that retinal abnormalities predict stroke independently
of traditional risk factors.26
The purpose of the present study is to examine the
association between retinal microvascular abnormalities and
cognitive impairment in middle-aged persons free of stroke in
the ARIC study.
Methods
Study Population
The ARIC study included 15 792 women and men 45 to 64 years of
age at recruitment in 1987 through 1989.27 Population samples were
selected from 4 US communities: Forsyth County, North Carolina;
Jackson, Miss (blacks only); suburbs of Minneapolis, Minn; and
Washington County, Maryland.27 Of those examined at baseline
(visit 1), 92.9% of survivors returned for the visit 2 examination 3
years later, 86.2% of survivors returned for the visit 3 examination 6
years from baseline, and 80.5% of survivors returned for the visit 4
examination 9 years from baseline.
Retinal photographs of each participant were taken at visit 3.23 Of
the 12 887 who returned for visit 3, we excluded 38 whose race was
neither black nor white, 42 black residents in Minneapolis and
Maryland, and 174 who did not participate at visit 2. We then
excluded 2919 who were using central nervous system–relevant
medications (ie, antipsychotics, antidepressants, anxiolytics, narcotic
analgesics, anticonvulsants, and antineoplastic agents) and 265 with
a history of stroke up to visit 4, leaving 9623 eligible for these
analyses. Of these, 9 had missing blood pressure data, 162 had no
retinal photographs, and 544 had ungradable photographs, leaving
8734 who provided data for this study. Characteristics of participants
with and without gradable retinal photographs have been previously
reported.25 Persons with gradable photographs were younger and
more likely to be white but did not differ by sex or smoking status.
Retinal Grading and Definitions
The retinal photography procedure has previously been described in
detail.23 Briefly, photographs of the retina were taken of 1 randomly
selected eye after 5 minutes of dark adaptation. Trained and certified
graders, masked to participant characteristics, evaluated the photo-
graphic slides for microvascular abnormalities using standardized
protocols. Any retinopathy was defined as present if any of the
following lesions were detected: microaneurysms, retinal hemor-
rhages (blot or flame shaped), soft exudates, hard exudates, macular
edema, intraretinal microvascular abnormalities, venous beading,
new vessels at the disc or elsewhere, vitreous hemorrhage, disc
swelling, or laser photocoagulation scars.23 Similarly, arteriovenous
nicking and focal arteriolar narrowing were defined as present if
graded definite or probable. Generalized arteriolar narrowing was
quantified via a computer-assisted technique. The photographs were
digitized by a high-resolution scanner, and the diameters of individ-
ual arterioles and venules coursing through a specified zone sur-
rounding the optic disc were measured and summarized as the
arteriole-to-venule ratio (AVR). A smaller AVR represents narrower
arterioles (because venular diameters vary little),23 and generalized
arteriolar narrowing was defined as the lowest 20th percentile of the
sample AVR distribution.26 As previously reported, intragrader and
intergrader  statistics ranged from 0.61 to 1.00, respectively, for
retinopathy, arteriovenous nicking, and focal arteriolar narrowing.23
For AVR, intragrader and intergrader reliability coefficients were
0.84 and 0.79, respectively.
Cognitive Function Tests
Assessment of cognitive function in the ARIC study is described in
detail elsewhere.10,13 All participants at visits 2 and 4 had the
following 3 neuropsychological tests: the Delayed Word Recall
Test,28 the Digit Symbol Subtest of the Wechsler Adult Intelligence
Scale–Revised,29 and the Word Fluency Test of the Multilingual
Aphasia Examination.30 Trained interviewers administered these
tests in a standardized order during 1 session in a quiet room.
The Delayed Word Recall Test is an evaluation of verbal learning
and recent memory that requires the person to recall 10 common
nouns after a 5-minute interval during which another psychometric
test is given.28 Test scores ranged from 0 to 10 words recalled.
Test-retest reliability coefficient over 6 months has been reported to
be 0.75 in normal elderly individuals.28
The Digit Symbol Subtest is a paper-and-pencil task requiring
timed translation of numbers1–9 to symbols with a key. The test
measures psychomotor performance and is relatively unaffected by
intellectual ability, memory, or learning.29 It appears to be a sensitive
indicator of brain damage, but it is not useful in localizing a lesion.31
The test is scored as the number of numbers translated to symbols
correctly within 90 seconds, up to a possible maximum of 93.
Test-retest reliability coefficient over 2 to 5 weeks has been reported
to be 0.82 in middle-aged persons.29
The Word Fluency Test requires the participant to generate as
many words as possible beginning with the letters F, A, and S in 60
seconds for each letter. The test is particularly sensitive to damage in
the frontal lobes of the brain.30 The score is the total number of
words generated. Test-retest reliability coefficient based on an
alternate test form has been reported to be 0.82.30
Definition of Other Variables
Participants underwent standardized cardiovascular assessment at
each visit.32 Blood pressure was taken with a random-zero sphyg-
momanometer, and the mean of the last 2 measurements was used.
Mean arterial blood pressure was computed as two thirds of the
diastolic value plus one third of the systolic value, and the average of
this over the first 3 exams (ie, 6-year mean arterial blood pressure)
was included as a covariate in the assessment of the independence of
retinal abnormalities with cognitive impairment.26 Education, occu-
pation, diabetes and hypertension history, cigarette smoking, and
alcohol consumption were ascertained from examiner-administered
questionnaire. Diabetes mellitus was defined as fasting glucose
7.0 mmol/L, nonfasting glucose 11.1 mmol/L, or a self-reported
history of physician-diagnosed diabetes or treatment for diabetes.
Hypertension was defined as systolic blood pressure 140 mm Hg,
diastolic blood pressure 90 mm Hg, or use of antihypertensive
medication during the previous 2 weeks. Average internal carotid
intima-media wall thickness (IMT) was obtained from standardized
B-mode ultrasonograms.32 Blood collection and processing for total
plasma cholesterol, high-density lipoprotein (HDL) cholesterol, and
triglycerides are described elsewhere.32 All covariates were based on
visit 3 data, except for education and occupation (visit 1), carotid
artery IMT (visit 2), and mean arterial blood pressure (average of
visits 1 through 3).
Statistical Analysis
Cognitive function scores in the ARIC population were distributed
approximately normally and were treated as continuous variables in
the analysis.10,13 We evaluated associations of retinal lesions at visit
3 to cognitive test scores that were averaged over visits 2 and 4
among participants who attended all 3 examinations (n7526). We
additionally evaluated retinal associations to cognitive test scores of
visits 2 (n8694) and 4 (n7552) separately (results were similar
and not presented).
We used analysis of covariance to compare the mean cognitive test
scores in persons with and without a specific retinal lesion, adjusting
for age, sex, race, field center, education (attended grade school or
less, attended but did not graduate from high school, graduated from
high school, attended vocational school, attended college, attended
graduate school), and occupation (professional or manager, other). In
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multivariate models, we further adjusted for diabetes (yes/no),
fasting glucose (mmol/L), hypertension (yes/no), 6-year mean arte-
rial blood pressure (mm Hg), carotid artery IMT (mm), fasting total
cholesterol, HDL cholesterol and triglycerides (mmol/L), cigarette
smoking (ever/never), and alcohol consumption (ever/never).
To evaluate the retinal associations with extremes in cognitive
scores,33 we defined cognitive impairment as scores 2 SD or lower
than the mean scores with the following cutoffs: Delayed Word
Recall Test, 4; Digit Symbol Subtest, 20; and Word Fluency
Test, 11. For each test, we used logistic regression models to
determine the odds of cognitive impairment associated with specific
retinal lesions, adjusting for potential confounders.
Results
A comparison of characteristics between persons with and
without any retinopathy in the study population is shown in
Table 1. Persons with any retinopathy were older, more likely
to be black, and less likely to have a professional or
managerial occupation. After adjustment for age, sex, race,
and field center, persons with retinopathy were more likely to
have diabetes and higher fasting glucose levels, hypertension
and higher mean arterial blood pressure, and lower HDL
cholesterol but higher triglyceride levels.
The means (SD) of the average cognitive scores of visits 2
and 4 were as follows: 6.48 (1.3) for Delayed Word Recall,
45.7 (12.8) for Digit Symbol Subtest, and 34.1 (11.6) for
Word Fluency Test. After adjustment for age, sex, race, field
center, education, and occupation, mean scores of all 3 tests
were significantly lower in persons with any retinopathy,
microaneurysm, retinal hemorrhage, and soft exudates com-
pared with persons without these lesions (data not shown).
Adjustment for diabetes, hypertension, carotid IMT, and
other vascular risk factors did not substantially alter these
relations (Table 2).
Results of logistic regression models for cognitive impair-
ment are shown in Table 3. After adjustment, persons with
any retinopathy, microaneurysms, retinal hemorrhage, and
soft exudates were to 1.4 to 4.1 times more likely to have
cognitive impairment than persons without these lesions.
We repeated analyses in persons with and without hyper-
tension and diabetes separately because these conditions are
TABLE 1. Baseline Characteristics of Study Population by
Presence of Retinopathy
Adjusted Means or %*
P†
Retinopathy
Absent
(n8143)
Retinopathy
Present
(n590)
Age, y 53.7 54.5 0.001
Men, % 48.1 49.0 0.65
Black, % 27.3 29.9 0.001
High school graduate, % 81.8 79.3 0.12
Professional/manager, % 26.2 21.3 0.008
Diabetes, % 7.0 34.0 0.001
Fasting glucose, mmol/L 5.68 7.84 0.001
Hypertension, % 29.0 39.7 0.001
Mean arterial blood pressure, mm Hg 88.6 90.0 0.003
Total plasma cholesterol, mmol/L 5.55 5.51 0.45
HDL cholesterol, mmol/L 1.34 1.27 0.001
Total triglycerides, mmol/L 1.42 1.63 0.001
Cigarette smoking (current), % 21.7 23.0 0.46
Alcohol use (current), % 60.6 56.8 0.05
Alcohol use (past), % 15.9 17.8 0.23
*Means and proportions adjusted for age, sex, race, and field center (except for age,
men, and black, which are unadjusted for age, sex and race, respectively).
†P-value represents difference in adjusted means or proportions between
persons with and without any retinopathy.
TABLE 2. Multivariable-Adjusted Mean Cognitive Function Tests Scores by Presence of Retinal
Microvascular Abnormalities
n*
Delayed Word Recall Digit Symbol Subtest Word Fluency Test
Mean† SE P‡ Mean† SE P‡ Mean† SE P‡
Any retinopathy Present 429 6.49 0.06 0.001 44.8 0.44 0.02 33.1 0.49 0.02
Absent 6798 6.70 0.01 45.8 0.11 34.2 0.12
Microaneurysm Present 219 6.34 0.09 0.001 44.6 0.65 0.03 32.8 0.71 0.03
Absent 6686 6.71 0.02 46.1 0.11 34.3 0.12
Retinal hemorrhage Present 190 6.36 0.09 0.001 44.5 0.69 0.05 32.6 0.76 0.04
Absent 7015 6.70 0.01 45.9 0.11 34.2 0.12
Soft exudates Present 90 6.28 0.13 0.002 42.5 1.01 0.001 31.4 1.10 0.01
Absent 7249 6.69 0.01 45.9 0.11 34.2 0.12
Arteriovenous nicking Present 972 6.67 0.04 0.52 45.6 0.29 0.36 33.5 0.32 0.03
Absent 6340 6.69 0.02 45.9 0.12 34.3 0.13
Focal arteriolar narrowing Present 1050 6.79 0.04 0.02 46.3 0.29 0.16 34.3 0.32 0.75
Absent 6129 6.69 0.02 45.9 0.12 34.2 0.13
Generalized arteriolar narrowing Present 1300 6.68 0.03 0.40 46.1 0.25 0.49 34.3 0.29 0.82
Absent 5433 6.71 0.02 46.3 0.12 34.4 0.14
*Number of persons with and without a specific retinal lesion.
†Mean adjusted for age, sex, race, field center, education, occupation, diabetes, fasting glucose, hypertension, mean arterial blood pressure of visits
1 through 3, carotid IMT, cigarette smoking, alcohol consumption, fasting total and HDL cholesterol levels, and triglyceride levels.
‡P represents difference in means by presence of retinal lesion.
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known to influence retinopathy and cognitive function. The
overall pattern of associations was similar (Results based on
Delayed Word Recall scores are presented in Table 4).
Formal tests of interaction for hypertension and diabetes
status in the whole sample by inclusion of cross-product
terms (eg, any retinopathy times hypertension) in the logistic
regression models did not reveal significant interaction
(P0.20 for all terms).
Results were generally similar in analyses repeated sepa-
rately for demographic subgroups stratified by age (51 to 60
years, 61 to 70 years), sex, and race (data not shown). Finally,
we attempted to analyze the retinal associations with the
6-year change in cognitive tests scores from visits 2 to 4 (ie,
difference in scores between visits 2 and 4). However, the
change in scores was minimal in this middle-aged population
(eg, change in score for the Delayed Word Recall was 10%
of the SD of the mean score).
Discussion
In this population-based study of middle-aged people free of
stroke, various manifestations of retinal microvascular dis-
ease, determined by standardized grading of retinal photo-
graphs, were related to cognitive impairment, determined by
neuropsychological tests administered in a standardized set-
ting. For all 3 cognitive tests, persons with any retinopathy,
microaneurysms, retinal hemorrhage, and soft exudates had
significantly lower mean cognitive test scores and were 1.4 to
4.1 times more likely to have the lower extremes in these
scores (cognitive impairment) than persons without these
lesions, independent of diabetes, blood pressure, carotid IMT,
and other vascular risk factors. These associations were seen
in persons with and without diabetes and hypertension.
Our study provides further insights into the pathogenesis of
cognitive impairment. Although cerebral microvascular dis-
ease has been hypothesized to contribute to cognitive impair-
TABLE 3. Multivariable-Adjusted Odds Ratios for Cognitive Impairment* in
Association With Retinal Microvascular Abnormalities
Odds Ratio (95% Confidence Interval)†
Delayed Word Recall
(n299/7494‡)
Digit Symbol Subtest
(n260/7468‡)
Word Fluency Test
(n145/7479‡)
Any retinopathy 2.60 (1.70–3.99) 1.91 (1.04–3.49) 2.03 (1.07–3.86)
Microaneurysm 3.00 (1.81–4.98) 2.04 (1.00–4.15) 1.62 (0.74–3.54)
Retinal hemorrhage 3.39 (1.99–5.78) 1.99 (0.94–4.20) 4.10 (1.90–8.86)
Soft exudates 3.07 (1.53–6.17) 1.40 (0.54–3.66) 2.27 (0.85–6.06)
Arteriovenous nicking 1.15 (0.81–1.62) 1.14 (0.71–1.84) 1.32 (0.81–2.14)
Focal arteriolar narrowing 0.60 (0.40–0.91) 1.31 (0.80–2.15) 1.24 (0.76–2.03)
Generalized arteriolar narrowing 1.10 (0.80–1.49) 1.08 (0.69–1.69) 1.37 (0.88–2.12)
*Cognitive impairment defined as 2 SD or lower from the mean cognitive test scores with the
following cutoffs: 4 for Delayed Word Recall, 20 for Digit Symbol Subtest, and 11 for Word
Fluency Test.
†Odds ratio (95% confidence interval) for cognitive impairment in association with a specific retinal
lesion adjusted for age, sex, race, field center, education, occupation, diabetes, fasting glucose,
hypertension and mean arterial blood pressure averaged over visits 1 through 3, carotid IMT, cigarette
smoking, alcohol consumption, fasting total and HDL cholesterol levels, and triglyceride levels.
‡Number of persons with cognitive impairment/number at risk.
TABLE 4. Multivariable-Adjusted Odds Ratios for Cognitive Impairment* (Based on Delayed Word Recall
Scores) in Association With Retinal Microvascular Abnormalities by Hypertension and Diabetes Status
Odds Ratio (95% Confidence Interval)†
Hypertension
(n133/2737‡)
No Hypertension
(n166/4757‡)
Diabetes
(n59/950‡)
No Diabetes
(n240/6541‡)
Any retinopathy 2.65 (1.52, 4.60) 2.59 (1.29, 5.19) 2.20 (1.09, 4.41) 2.58 (1.48, 4.49)
Microaneurysm 2.53 (1.30, 4.91) 3.00 (1.81, 4.98) 2.75 (1.32, 5.72) 2.60 (1.24, 5.48)
Retinal hemorrhage 4.69 (2.49, 8.81) 3.39 (1.99, 5.78) 3.59 (1.70, 7.59) 2.70 (1.16, 6.27)
Soft exudates 3.63 (1.59, 8.30) 3.07 (1.53, 6.17) 1.92 (0.74, 5.04) 5.07 (1.87, 13.77)
Arteriovenous nicking 1.17 (0.73, 1.88) 1.15 (0.81, 1.62) 1.63 (0.75, 3.51) 1.05 (0.71, 1.56)
Focal arteriolar narrowing 0.73 (0.44, 1.22) 0.60 (0.40, 0.91) 0.98 (0.44, 2.19) 0.52 (0.32, 0.84)
Generalized arteriolar narrowing 1.45 (0.95, 2.23) 0.80 (0.50, 1.31) 0.61 (0.27, 1.37) 1.26 (0.89, 1.77)
*Cognitive impairment defined as 2 SD or lower from the mean Delayed Word Recall scores (score of 4).
†Odds ratio (95% confidence interval) for cognitive impairment in association with a specific retinal lesion adjusted for age, sex,
race, field center, education, occupation, diabetes, fasting glucose, hypertension, mean arterial blood pressure averaged over visits
1 through 3, carotid IMT, cigarette smoking, alcohol consumption, fasting total and HDL cholesterol levels, and triglyceride levels.
‡Number of persons with cognitive impairment/number at risk.
1490 Stroke June 2002
ment,4–6 data to support such a hypothesis are sparse. Some
histopathological studies show Alzheimer’s disease to be
associated with numerous structural and physiological alter-
ations of the cerebral microvasculature, including cerebral
arteriolar narrowing,14 arteriolar tortuosity,15 capillary mi-
croaneurysms,17 endothelial cell dysfunction,14 and break-
down of the blood-brain barrier.16 One theory is that these
anatomic alterations lead to abnormal microvascular flow
patterns, impairment in the delivery of nutrients to susceptible
neurons, reactive astrocytosis, and finally formation of
plaques and neurofibrillary tangles characteristic of severe
dementia.6 However, because diseases of the cerebral micro-
circulation are difficult to assess in vivo, the retinal micro-
vasculature provides a useful noninvasive approach to study
the consequences of cerebral microvascular disease. Retinal
microvascular abnormalities related to aging and hyperten-
sion have been reported to correlate closely with pathological
changes in the cerebral microcirculation among stroke dece-
dents34 and have been found in epidemiological studies to be
associated with clinical stroke,26,35,36 lacunar infarct,37 and
cerebral white-matter lesions.38 Thus, our study supports the
hypothesis that cerebral microvascular disease may play an
important role in the development of cognitive impairment.
Additionally, these findings offer clues to the specific
pathophysiological processes that occur in the cerebral mi-
crocirculation of persons with cognitive impairment. The
retinal lesions that were related most consistently to lower
cognitive scores (eg, microaneurysm, retinal hemorrhages)
are indicators of more severe retinal microvascular disease
and are usually seen when there is a breakdown in the
blood-retinal barrier.21,22 In contrast, other retinal character-
istics such as arteriovenous nicking and arteriolar narrowing,
which reflect milder microvascular changes,21,22 appear to be
related weakly to cognitive impairment. We have also previ-
ously shown that incident stroke was more strongly related to
retinopathy (multivariable-adjusted relative risk, 2.6) than
arteriovenous nicking (multivariable-adjusted relative risk,
1.6) and arteriolar narrowing (multivariable-adjusted relative
risk, 1.2).26 Thus, the association with retinopathy but not
with arteriovenous nicking and arteriolar narrowing suggests
that disruption of the blood-brain barrier of the cerebral
microcirculation may be an important pathological feature in
the development of stroke and cognitive impairment.16
From a clinical perspective, these data provide additional
evidence that cognitive impairment may have a vascular
component and may therefore be amenable to treatment and
preventive strategies targeted at vascular diseases.39 It is less
clear that retinal lesions provide useful independent informa-
tion regarding risk of cognitive impairment and dementia.
Retinopathy is infrequent in the general population, and the
retinal assessment in the ARIC study was performed with
standardized photographic grading. In addition, differences in
cognitive function scores between persons with and without
retinopathy were small although statistically significant. Nev-
ertheless, modest deficits detected in midlife may reflect risk
of future dementia.39
Limitations of this study should be mentioned. First,
because retinal and cognitive assessments were at different
study visits, we could compare only retinal microvascular
data collected at visit 3 with the average of cognitive tests
scores 3 years before (visit 2) and after (visit 4) the retinal
examination. This makes it difficult to distinguish clearly
cause and effect, although it seems unlikely that cognitive
function affects the development of retinal microvascular
lesions. Second, selection bias may have obscured some
relevant associations and enhanced others. For example, if
persons with retinal abnormalities with cognitive impairment
were more likely excluded because of ungradable photo-
graphs (or other reasons), the observed associations would be
falsely attenuated. Finally, visual acuity data were not avail-
able, and biases could result if those who could not optimally
perform the cognitive tests had visual impairment. However,
retinal microvascular changes evaluated in this study are not
known to be an important cause of visual impairment.40
In conclusion, we found that in middle-aged persons
without stroke, signs of retinal microvascular disease are
independently associated with lower cognitive function. The
associations suggest that cerebral microvascular disease may
be important in the pathogenesis of cognitive impairment.
Longitudinal data may clarify the temporal sequence of these
associations and the eventual clinical significance of these
small, early cognitive function changes.
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